Kendle

ICON, Kendle Finish Strong 2008 on Soft Side

Monday, March 2, 2009 08:00 AM

It was another quarter of ups and downs for the clinical trial industry as contract research organizations (CROs) struggled through project delays and customer hesitation brought on by the unstable economy. In spite of the challenges, however, two CROs—ICON and Kendle—finished the year on top.

More... »

Kendle’s Year-End Income Up 57%

Wednesday, February 25, 2009 07:25 AM

Cincinnati-based contract research organization (CRO) Kendle reported full year 2008 net service revenues of $475.1 million, an increase of 19% over the same period last year. Net service revenues for the fourth quarter were $109.2 million, up 5% over the same period 2007.

More... »

ICON Trims Revenue Outlook, Boosts Profits

Monday, January 19, 2009 09:13 AM

While Kendle and Parexel became the latest contract research organizations (CROs) to lower their profit and revenue outlooks last week, one CRO actually increased its earnings expectations.

More... »

Kendle Lowers 2008 Guidance

Tuesday, January 13, 2009 09:00 AM

Cincinnati, Ohio-based Kendle is the latest contract research organization (CRO) to reduce its full year 2008 guidance as a result of the negative effect of foreign exchange rates.

More... »

Etrials Appoints Permanent CEO

Friday, November 14, 2008 09:00 AM

Just a day after releasing disappointing third quarter results, Morrisville, N.C.-based eClinical company etrials named a new president and CEO, M. Denis Connaghan, replacing interim president and CEO Chuck Piccirillo. Piccirillo, who will resume his position as vice president of technology, has served as interim CEO since the resignation of Eugene “Chip” Jennings in July. Connaghan was formerly managing director within Marsh USA’s Global Operations.

More... »

Kendle’s Q3 Revenues Up 25%

Wednesday, November 5, 2008 01:02 PM

Cincinnati-based contract research organization (CRO) Kendle reported third quarter net service revenues of $124.8 million, an increase of 25% compared with the same period last year. Approximately 6% of the CRO’s revenue growth resulted from the June acquisition of DecisionLine, a Toronto-based phase I company focused on the central nervous system (CNS).

More... »

Former etrials COO Named PDS President

Thursday, October 2, 2008 12:08 PM

Former etrials chief operating officer Peter S. Benton is the newly named president of Phoenix Data Systems (PDS), the eClinical division of Newtown, Pa.-based CRO Bio-Imaging Technologies. Benton, whose position at etrials was eliminated in April, will succeed Dr. William Claypool, who is leaving PDS to start a pharmaceutical development consulting company. Bio-Imaging acquired PDS earlier this year.

More... »

Kendle's Global CRO Growth Story Continues with Record Quarter

Thursday, August 7, 2008 07:30 AM

On a day when contract research organization (CRO) Covance announced a blockbuster $1.6 billion deal with Eli Lilly, the global CRO growth story got another big boost when Kendle reported record financial results for its second quarter.

More... »